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Vitamin E is a lipophilic vitamin playing an essential role in human health. Due to 24 
oxidative instability, it presents fast degradation and bioactivity loss. In this study, 25 
vitamin E-loaded Pickering emulsions stabilized by nano-hydroxyapatite (n-HAp) were 26 
produced using a static mixer (NETmix), a technique enabling continuous production and 27 
droplet size tailoring. Thus, oil-in-water (O/W) emulsions containing vitamin E at a 28 
content of 1mg/mL were produced with different droplet sizes (7.53, 11.56 and 17.72 µm) 29 
using an O/W ratio of 20/80 (v/v). Their stability during in vitro gastrointestinal digestion 30 
and vitamin E bioaccessibility were investigated. It was observed that n-HAp particles 31 
disrupt in the stomach and subsequently aggregate as random calcium phosphates in the 32 
small intestine, leading to low vitamin E bioaccessibility due to oil entrapment. The 33 
emulsion showing the highest vitamin E bioaccessibility (3.29±0.57%, sample with the 34 
larger average droplet size) was used to produce fortified gelatine and milk, resulting in 35 
an increased bioaccessibility (10.87±1.04% and 18.07±2.90%, respectively). This fact 36 
was associated with the presence of macronutrients and the lower n-HAp content. Overall, 37 
n-HAp Pickering emulsions offer advantages for vitamin E encapsulation directed to 38 
fortified foods development, a process able to be extended to other lipophilic vitamins. 39 
Keywords: NETmix; Pickering emulsions; Lipophilic vitamin; in vitro digestion; 40 









1 Introduction 42 
Vitamin E is a lipophilic vitamin comprising eight compounds, namely: 𝛼-, 𝛽-, 𝛾- and 𝛿- 43 
tocopherol and tocotrienol. Among them, 𝛼-tocopherol is the most abundant and 44 
biologically active form (Borel, Preveraud, & Desmarchelier, 2013; Burton, 1994; Yang 45 
& McClements, 2013). Vitamin E can be naturally found in fresh fruits (kiwi, mango, 46 
tomato), vegetables (broccoli, lettuce) and dry fruits (sunflower seeds, hazelnuts, peanuts, 47 
almonds) (Borel et al., 2013). Vitamin E intake can avoid cellular ageing and reduce 48 
diseases such as dementia, cancer and cardiovascular disorders (Katouzian & Jafari, 49 
2016; Niki & Noguchi, 2020; Yang, Decker, Xiao, & McClements, 2015). 50 
Vitamin E is currently added to fortified foods, beverages and supplements (Lv, Zhang, 51 
Tan, Zhang, & McClements, 2019). However, its effectiveness is not easy to achieve due 52 
to its high lipophilic character. Vitamin E cannot be effectively incorporated into aqueous 53 
systems and presents oxidative instability, degrading fast and losing bioactivity 54 
(Hategekimana & Zhong, 2015; Katouzian & Jafari, 2016). For these reasons, vitamin E 55 
is often encapsulated to increase stability, bioavailability, and compatibility with 56 
hydrophilic food matrices (Hategekimana, Masamba, Ma, & Zhong, 2015; Lv et al., 2019; 57 
Mujica-Álvarez et al., 2020; Yang & McClements, 2013). 58 
Among the reported encapsulation systems, Pickering emulsions (PEs), which are 59 
emulsifier-free systems, start to be proposed as solutions to increase vitamins 60 
bioavailability (Hategekimana et al., 2015; Mitbumrung, Suphantharika, McClements, & 61 
Winuprasith, 2019), even some challenges still need to be surpassed. In the work of Lv et 62 
al. (2019) dealing with different Pickering stabilizers, vitamin E bioaccessibility was 63 
found to be more effective with whey protein systems than with gum Arabic and Quillaja 64 
saponin. Comparatively with Tween 80 stabilized emulsions, Zhou et al. (2020) reported 65 









aggregation in the gastrointestinal tract (GIT). Moreover, Winuprasith et al. (2018) who 67 
studied vitamin D3-loaded nanofibrillated cellulose PEs, reported a decreased 68 
bioaccessibility rate as the cellulose concentration increased. 69 
The reported studies evidence that the bioaccessibility of lipophilic vitamins-loaded PEs 70 
depends on several factors. These can be related with the emulsion itself (type of particles, 71 
oil phase composition, O/W ratio, and O/W interfacial properties), or with the 72 
gastrointestinal environment (presence of calcium ions, bile salts, and phospholipids), 73 
which can affect (positively or negatively) the bioaccessibility (Yang et al., 2015). 74 
Namely, Zhou et al. (2021) showed that titanium dioxide and nanochitin, when added to 75 
milk conjunctly with vitamin D3, did not significantly affect vitamin bioaccessibility. In 76 
another study, Tan et al. (2020) reported that chitosan reduced vitamin D3 bioaccessibility 77 
by binding to the mixed micelles. Summarizing, these results highlight the importance to 78 
proceed with the testing of different Pickering systems and their impact on 79 
bioaccessibility. 80 
In this context, the purpose of the present work was to study vitamin E-loaded n-HAp 81 
Pickering emulsions, which were produced using NETmix technology (a static mixer 82 
enabling continuous mode), trying to evidence the impact of their droplet size on vitamin 83 
E stability, bioaccessibility and bioavailability. HAp is a biocompatible inorganic 84 
material mostly used in biomedical and biotechnological applications. This scenario is 85 
changing with some food-grade HAps emerging commercially. Thus, following some 86 
reported results pointed out Pickering emulsions as promising systems to improve 87 
vitamins bioaccessibility, n-HAp stabilized Pickering emulsions were firstly tested as 88 
vitamin E carriers, then used to produce fortified milk gelatine and milk. To the best of 89 








emulsions as vitamin E carriers and the study of emulsion droplet size effect on 91 
bioaccessibility. 92 
2 Experimental methods 93 
2.1 Materials 94 
The nanoXIM-CarePaste, hydroxyapatite aqueous paste supplied by Fluidinova S.A., is 95 
composed of 15.5±0.5 (wt%) of HAp nanoparticles (n-HAp) with particle size <50 nm, 96 
4.5±0.5 (wt%) KCl and a water content 81.0 (wt%). This n-HAp has a composition 97 
similar to the one commercialized as food grade (nanoXIM-FoodPaste). Sunflower oil, a 98 
100% vegetable oil obtained from sunflower seeds with a fatty acids composition per 99 
100g of 10 g, 28 g and 53 g of saturated, monosaturated and polysaturated, respectively, 100 
milk (semi-skimmed) and neutral gelatine (in powder) were purchased from a local 101 
supermarket. Other technical properties of the oil include, refractive index of 1.473 102 
(determined by refractometry, BOECO Digital, Germany ), acid value of 0.72 mg KOH/g, 103 
free fatty acids in oleic acid equivalents of 0.36% (Ca 5a-40, according to AOCS (2003)), 104 
viscosity of 0.06 Pa·s (determined by rheometry, Anton Paar, GmbH, Austria), and 105 
density of 923 kg/m3 (determined by pycnometry). Fluorescent dyes (Nile red - technical 106 
grade, and Nile blue A - ≥75%) and 𝛼-tocopherol (98%), further referred as “vitamin E”, 107 
were obtained from Sigma-Aldrich. Isopropyl alcohol (99.7%) was purchased from 108 
Riedel-de Haen. Pepsin from porcine gastric mucosa (≥2500 U·mg-1), bile extract 109 
porcine, pancreatin from porcine pancreas (8x USP), Pefabloc® SC and the salts used for 110 
the preparation of oral, gastric and intestinal electrolyte solutions were purchased from 111 
Sigma-Aldrich. Ethanol (99.8%) and methanol (95%) were purchased from Fisher 112 









Q water purification system (TGI Pure Water Systems, Greenville, SC, USA), was used. 114 
All other chemicals were of analytical grade. 115 
2.2 Vitamin E-loaded Pickering emulsions production and characterization 116 
Oil-in-water (O/W) PEs were prepared, in continuous mode, according to a previously 117 
reported technology, NETmix (Ribeiro, Manrique, Barreiro, Lopes, & Dias, 2021). 118 
Briefly, the PEs were obtained using an O/W ratio of 20:80 (v/v). The aqueous phase 119 
corresponds to n-HAp (5 wt%) dispersed in water, and the oil phase to a mixture of 120 
sunflower oil and vitamin E. Vitamin E was mixed directly in the sunflower oil at a 121 
content of 5 mg/mL (oil phase). For each sample 230 mL have been produced. 122 
NETmix (Figure 1) comprises consecutive rows of mixing chambers interlinked by 123 
channels, forming a network. The mixing chambers enable successive and well-localized 124 
mixing points along the reactor, promoting an easily reproducible emulsification step. To 125 
produce the PEs, the NETmix procedure comprised a first step where the aqueous and oil 126 
phases are mixed using two peristaltic pumps (Ismatec, Germany) to form a coarse 127 
emulsion (pre-emulsion, configuration A). Then, droplet size reduction is achieved by 128 
recirculating the pre-emulsion in the NETmix using a diaphragm pump (Almatec, 129 
Germany) (configuration B). Recirculation increases the residence time in the NETmix, 130 
leading to droplet size reduction. The production conditions in terms of Reynolds number 131 
(300 and 400) and the number of cycles (5, 10 and 17) varied according to the required 132 
droplet size, as described in Table 1. To avoid vitamin E degradation a cooling bath 133 
(15 ºC, Paar physica viscotherm VT2, The Netherlands) was coupled to the NETmix to 134 
control emulsion temperature (18-20 ºC). PEs with a proximate droplet size of 7, 11 and 135 
18 µm were produced and named as NET-low, NET-middle and NET-high, respectively. 136 









particle size analyser (Beckman Coulter LS230; California) and zeta potential using a 138 
Zetaziser Nano ZS90 (Malvern Instruments, United Kingdom). 139 
Table 1: NETmix conditions used to produce the n-HAp stabilized Pickering emulsions. 140 
SAMPLE NAME Re CYCLES 
NET-low 400 17 
NET-middle 400 5 
NET-high 300 10 
 141 
 142 
Figure 1: Experimental NETmix set-up used to produce PEs: configuration for the first pass (pre-143 
emulsion preparation (A), and configuration for the recirculation mode (B). 144 
2.3 Vitamin E-fortified foods production 145 
To produce the vitamin E-fortified foods, vitamin E-loaded PEs were incorporated in 146 
neutral gelatine and semi-skimmed milk. A ratio of 1:2 of PE to the food matrix was used. 147 
The final concentration of vitamin E in the food matrix was 0.33 mg/mL, higher than the 148 
daily reference intakes of Regulation (EU) no 1169/2011 (1.8 mg or 0.9 mg of vitamin E 149 
per 100 g of food or 100 mL of beverages, respectively). This value was used to facilitate 150 
the quantification of vitamin E by ultra-performance liquid chromatography (UPLC) after 151 









was stirred at 50 rpm for 1 min and stored in the fridge. For the fortified gelatine, 1.5 g 153 
of powder gelatine were hydrated with 25 mL of distilled water under stirring, completed 154 
with 25 mL at 50 ºC (total water 50 mL), then added with 25 mL of the PE. After stirring 155 
(50 rpm) for 1 min the final mixture was stored in the fridge to solidify. 156 
2.4 In vitro gastrointestinal (GI) digestion studies 157 
The produced vitamin E-loaded PEs (NET-low, NET-middle and NET-high) and fortified 158 
foods (milk and gelatine with vitamin E-loaded PEs) were digested in vitro to check 159 
emulsions' behaviour in case of vitamin E-loaded PEs, and vitamin E bioaccessibility for 160 
emulsions and fortified food samples. The harmonized static in vitro digestion model 161 
described by Minekus et al. (2014) was used. This is a three-stage model comprising the 162 
simulation of the mouth, stomach and small intestine conditions. The composition of the 163 
simulated digestion fluids is presented in Table 2. All fluids and samples (vitamin E-164 
loaded PEs, fortified milk and gelatine) were pre-heated at 37 ºC during 5 min. 165 
For the oral stage, simulated salivary fluid (SSF), CaCl2(H2O)2 0.3 M (to achieve 0.75 166 
mM at the final mixture) and Milli-Q water were added to the tested sample (5 mL). The 167 
mixture was incubated at 37 ºC for 2 min under orbital stirring at 120 rpm. A final ratio 168 
of food to SSF of 1:1 (v/v) was targeted. Since the samples did not have starch, α-amylase 169 
was not used (Brodkorb et al., 2019). In the gastric stage, simulated gastric fluid (SGF), 170 
CaCl2(H2O)2 0.3 M (to achieve 0.075 mM at the final mixture) and pepsin solution (with 171 
the final activity of 2000 U/mL in the final mixture) were added to the previous mixture. 172 
The pH was adjusted to 3.0 with HCl 1 M, and Milli-Q water was added to make up the 173 
final volume, and the mixture incubated for 2 h at 37 ºC under orbital stirring at 120 rpm. 174 
A final ratio of oral sample to SGF of 1:1 (v/v) was targeted. The intestinal stage consisted 175 
of simulated intestinal fluid (SIF), CaCl2(H2O)2 0.3 M (to achieve 0.3 mM at the final 176 









the final activity of 100 U/mL in the final mixture). The pH was adjusted to 7.0 with 178 
NaOH 1 M or HCl 1 M, then Milli-Q water was added to achieve the final volume. The 179 
samples were incubated for 2 h at 37 ºC under orbital stirring at 120 rpm. A final ratio of 180 
gastric sample to SIF of 1:1 (v/v) was targeted. 181 
After each stage, samples were collected to check the morphology and stability of vitamin 182 
E-loaded PEs along the simulated gastrointestinal tract. The samples collected at the end 183 
of the gastric stage were maintained in an ice bath to decrease the pepsin activity until 184 
analysis. After complete digestion, the reaction was stopped by adding the enzyme 185 
inhibitor Pefabloc® (1 mM) (10 µL for each 1 mL of the sample). The sample provided 186 
after the intestinal stage was used to analyse bioaccessibility and stability of vitamin E-187 
loaded PEs and fortified foods. All the samples were tested at least in triplicate. 188 
 189 
Table 2: Composition of simulated digestion fluids. 190 
SALT SOLUTION SSF (mM) SGF (mM) SIF (mM) 
KCl 15.1 6.9 6.8 
KH2PO4 3.7 0.9 0.8 
NaHCO3 13.6 25 85 
NaCl - 47.2 38.4 
MgCl2(H2O)6 0.15 0.12 0.33 
(NH4)2CO3 0.06 0.5 - 
HCl 1.1 15.6 8.4 
SSF: simulated salivary fluid; SGF: simulated gastric fluid; SIF: simulated intestinal fluid. 191 
2.5 Pickering emulsions digesta characterization 192 
Zeta potential can reveal emulsion stability. The emulsion can be considered stable for 193 
high positive (≥30) or high negative (≤-30) values. The determination was done with a 194 
Zetaziser Nano ZS90 (Malvern Instruments, United Kingdom). For that, the PEs were 195 









capillary Zeta cell (ref: DS7010). The measurement was conducted at 25 ºC. Each sample 197 
was measured in triplicate and the data expressed as average±standard deviation (SD). 198 
To check PEs morphology along digestion, the samples collected at each GIT stage were 199 
analysed by CLSM using a Leica TCS-SP5 AOBS (Leica Microsystems, Germany). 200 
CLSM is a microscopic technique allowing to observe the particles and oil phase. The 201 
digesta sample (100µL) was stained with a mixture of Nile red at 0.1% (w/v) and Nile 202 
blue A at 0.1% w/v dissolved in isopropyl alcohol (10µL). Nile blue and Nile red are able 203 
to dye the solid particles and the oil phase, respectively. The dyed digesta PE was placed 204 
on a slide, and fluorescent dyes excited at 488 nm (Nile red) and at 633 nm (Nile blue A). 205 
The images were digitally recorded and processed with a LASX software. The initial PE 206 
was also analysed. 207 
2.6 Vitamin E bioaccessibility, stability and bioavailability evaluation 208 
After passing through the three simulated GIT stages, vitamin E concentration was 209 
determined according to the procedure described by Lv et al. (2019) with some 210 
modifications. Briefly, the digesta obtained after the small intestine stage was centrifuged 211 
(Allegra 64R, Beckman Coulter Inc., USA) at 18700 g and 4 °C for 30 min to obtain the 212 
micellar phase. Before UPLC (Nexera X2, Shimadzu, Japan) analysis, vitamin E was 213 
extracted from digesta and micellar phase samples. For that, 3 mL of the sample were 214 
mixed with 3 mL of a hexane/ethanol mixture (1/1, v/v), then centrifuged at 4000 rpm for 215 
2 min (Multifuge X3R, Heraeus, Germany) to obtain a supernatant layer. This extraction 216 
was repeated three times, and the obtained supernatant layers mixed and dried under 217 
nitrogen. The dried samples were dissolved in methanol and filtered through a 0.22 μm 218 
filter. The vitamin E concentration was determined using a UPLC with a C18 column 219 
(150×2.1 mm, 1.7 μm, Kinetex®) using a mixture of 95% methanol and 5% double-220 









column temperature of 40 ºC and a 10 µL injection volume were used. The detection 222 
wavelength for vitamin E was 295 nm. 223 
Vitamin bioaccessibility was determined by measuring the concentration of vitamin E in 224 






Stability was calculated as the vitamin E fraction remaining untransformed in the small 226 






where, 𝐶𝑖𝑛𝑖𝑡𝑖𝑎𝑙 represents the vitamin E concentration in the initial stage, i.e., the vitamin 228 
E concentration of the PE (1 mg/mL). 229 
The bioavailability of the vitamin E was then estimated as the product of bioaccessibility 230 
and stability 231 
𝐵𝑖𝑜𝑎𝑣𝑎𝑖𝑙𝑎𝑏𝑖𝑙𝑖𝑡𝑦 = 𝐵𝑖𝑜𝑎𝑐𝑐𝑒𝑠𝑠𝑖𝑏𝑖𝑙𝑖𝑡𝑦 × 𝑆𝑡𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (3) 
The calculated bioavailability corresponds to an estimative of vitamin E absorption. 232 
2.7 Statistical analysis 233 
The digestion and bioaccessibility studies of PEs and fortified foods were done in 234 
triplicate and duplicate, respectively. Data is presented as average±SD. The statistical 235 
analysis was performed using the commercial software IBM SPSS statistics (version 27.0, 236 
SPSS Inc., Chicago, IL, USA). One-way analysis of variance of independent variables 237 
followed by Tukey’s test was carried out on the digesta PEs measurements to establish 238 
significant differences (p<0.05). For fortified foods measurements, a t-test was used to 239 









3 Results and discussion 241 
3.1 Vitamin E-loaded Pickering emulsions characterization 242 
The vitamin E-loaded PEs with tailored droplet average sizes were produced using 243 
NETmix according to the parameters described in Table 1. The influence of these 244 
parameters in the average droplet size of the emulsion was previously reported by Ribeiro 245 
et al. (2021), and adopted in this study since the used vitamin E concentration did not 246 
impacted the sunflower oil viscosity (0.06 Pa·s). 247 
Figure 2 shows the optical microscopy images of NET-low, NET-middle and NET-high 248 
samples with the determined droplet size distributions, average droplet size (7.53, 11.56 249 
and 17.72 µm, respectively) and zeta potential (+31.18, +32.20, and +32.05 mV, 250 
respectively). In terms of the zeta potential, similar values were obtained for the 3 251 
samples; namely, the produced PEs were characterized by a strong positive zeta potential, 252 
indicating that droplet aggregation is inhibited resulting in stable emulsions due to an 253 










Figure 2: Optical images (A), droplet size distributions (B), average size distributions (µm) and zeta 256 
potential (mV) (C) of the produced vitamin E-loaded Pickering emulsions produced using NETmix 257 
technology. 258 
3.2 Vitamin E-loaded Pickering emulsions gastrointestinal digestion 259 
The vitamin E-loaded PEs were digested in vitro through a simulated GIT. After each 260 
stage (mouth, gastric and intestine phases), a sample was collected for analysis, namely 261 
concerning for microstructure (CLSM), zeta potential, vitamin E bioaccessibility and 262 
stability analysis. 263 
3.2.1 Influence on microstructure morphology 264 
Figure 3 shows the CLSM analysis of the studied PEs (NET-low, NET-middle, and NET-265 
high) in the initial stage and throughout the simulated GIT. The red fluorescence colour 266 
represents n-HAp particles (dyed by Nile blue), whereas the green fluorescence colour 267 
represents the oil phase (stained by Nile red).  268 
At the initial stage, a packed n-HAp layer is observed around the oil droplets for all tested 269 
PEs, confirming the efficient stabilization role of the nanoparticles. After exposure to the 270 









digestion model. In this stage, no changes in the n-HAp stabilizing role were perceived, 272 
i.e., the n-HAp particles maintained their tight position at the oil surface. Also, for all the 273 
tested samples, no evident changes in the droplet size were observed, and no agglomerates 274 
were detected. 275 
In the stomach, the PEs face stringent conditions, namely they contact with gastric fluids 276 
characterized by a highly acidic pH (around 1-3), relatively high ionic strength (around 277 
150 mM), and a high enzymes content (McClements, 2016). The acquired CLSM images 278 
(Figure 3) revealed that this is the first local in GIT where the PEs undergo strong 279 
changes. Namely, it is evident that the n-HAp particles are not covering the oil droplets, 280 
i.e., they are not acting anymore as Pickering stabilizers in all tested PEs. The n-HAp 281 
particles seem to have disrupted, becoming dissolved in the aqueous medium, fact 282 
compatible with the observation of a quite uniform red background. In fact, the Nile blue, 283 
which dyes the hydrophilic compounds, might be staining the Ca2+ and PO4
2- species of 284 
the disrupted n-HAp particles, and other molecules resulting from the two digestive 285 
stages. These results are in agreement with Ramis, Coelho, Córdoba, Quadros, and Monjo 286 
(2018) that studied the n-HAp paste behaviour in simulated gastric fluid, identifying its 287 
rapid and complete dissolution under gastric environment after 7.5 min at 37 ºC. In this 288 
work, together with particle’s disruption, a slight oil droplet size increase was observed 289 
after exposure to gastric conditions, which may also be justified by the n-HAp detachment 290 
from the oil droplets facilitating coalescence.  291 
After passing the stomach, medium in which the n-HAp particles become completely 292 
dissolved, the digestion proceeds to the small intestine. Within this phase, the 293 
environment conditions change, namely the pH turn to neutral. Under these conditions, 294 
and as shown in the CLSM images taken after the intestine phase (Figure 3), appreciable 295 









stomach phase forms large and random calcium phosphate clusters upon in contact with 297 
neutral pH. This result corroborates the observations made by Epple (2018) that reported 298 
the precipitation of HAp in random calcium phosphate clusters at neutral pH after 299 
contacting acidic pH. 300 
The PEs tailored with different sizes showed similar behaviour during GI digestion with 301 
apparent stability in mouth stage, n-HAp disruption in gastric conditions and aggregates 302 
formation in intestinal conditions. However, NET-low PE has larger aggregates than the 303 
other samples after intestinal phase (Figure 3). 304 
 305 
Figure 3: Overlapped CLMS images of the vitamin E loaded Pickering emulsions with different sizes 306 
(NET-low= ~7 µm, NET-middle: ~11 µm; NET-high: ~18 µm) after each stage of digestion (mouth, 307 
stomach and small intestine), comparatively with the initial emulsion. The n-HAp particles and the oil 308 
droplets are presented as red and green colour, respectively. For interpretation of the references to the 309 
colour in this figure legend, the reader is referred to the web version of the article. The images were taken 310 









3.2.2 Influence on zeta potential 312 
Figure 4 shows the zeta potential of the studied PEs (NET-low, NET-middle, NET-high) 313 
throughout the simulated GIT. For comparison purposes, the zeta potential of the initial 314 
emulsions is included. The statistical analysis was done for each stage by comparing the 315 
zeta potential value of the three tested emulsions with different droplet size. It was 316 
observed that the value changes throughout the GIT, including the surface charge shifts 317 
from positive to negative between the mouth and stomach. The three emulsions presented 318 
similar behaviour for all GIT stages (p<0.05). 319 
The contact with the mouth promoted an appreciable decrease in the zeta potential 320 
magnitude (from approximately from 32 mV to 16 mV), probably associated with the 321 
neutral pH of this stage and the adsorption of ionic species at the droplets’ surface. After 322 
mouth stage, no statistical differences were observed between the three emulsions 323 
(p<0.05) meaning a similar behaviour for the PEs regardless the size. These results 324 
suggest that PEs become more prone to instabilities after the mouth stage. In accordance, 325 
other authors working with PEs stabilized with nanofibrillated cellulose observed small 326 
changes in the droplet size and morphology after this first digestion phase, which was 327 
related to mucin presence (Winuprasith et al., 2018). 328 
Upon in the stomach, the PEs zeta potential becomes low in magnitude and negative 329 
(around -3 mV) and once again no statistical differences were observed between the three 330 
emulsions (p<0.05). This change can be attributed to the highly acidic pH of the gastric 331 
fluids together with the presence of enzymes (i.e., pepsin), which can lead to the 332 
adsorption of negatively charged molecules neutralizing the positive charge (Zhou et al., 333 
2020). Also, the high ionic strength medium can have contributed to the emulsion 334 
destabilization. These observations agree with the CLSM images acquired after the 335 









In the small intestine, all the tested PEs presented a relatively strong negative zeta 337 
potential (but not high enough to be considered stable), which can be attributed to the 338 
presence of bile acids, phospholipids, and free fatty acids generated from the digestion of 339 
the emulsified oil (triglycerides). These molecules are negatively charged, leading to a 340 
zeta potential decrease. This observation is in accordance with the work of Zhou et al. 341 
(2020) that reported a strong zeta potential decrease for emulsions after the small intestine 342 
stage, fact associated with the presence of bile acids and peptides. Comparing the three 343 
emulsions, after small intestine stage there was significant differences (p<0.05), namely 344 
between NET-low and NET-high. NET-high had stronger negative zeta potential value, 345 
possibly indicating more effective adherence of the bile acids and others species at the 346 
cluster’s surface. 347 
 348 
Figure 4: Zeta potential of the vitamin E-loaded Pickering emulsions (NET-low= ~7 µm, NET-middle: 349 
~11 µm; NET-high: ~18 µm) along the gastrointestinal tract (mouth, stomach and small intestine), 350 
comparatively with the initial emulsion. In each GIT stage, different letters represent significant 351 
differences between the Pickering emulsions (p<0.05). 352 
 353 
3.2.3 Influence on vitamin E bioaccessibility and stability 354 
In this section, the influence of the GI digestion on vitamin E stability and bioaccessibility 355 







































emulsions for each evaluated parameter. In general, all PEs presented a high vitamin E 357 
stability. The NET-high sample showed the lowest and statistically different vitamin E 358 
stability followed by NET-low and NET-middle, respectively, 28.9±2.59%, 32.1±1.43% 359 
and 33.8±1.53% (p<0.05). However, all emulsions exhibited low vitamin E 360 
bioaccessibility, with NET-high sample presenting a slightly higher and statistically 361 
different value, comparatively with NET-low and NET-middle, respectively, 362 
3.29±0.57%, 2.15±0.15% and 2.03±0.12% (p<0.05). Therefore, NET-high sample 363 
presented the highest value of calculated bioavailability, followed by NET-middle and 364 
NET-low, 0.94±0.15%, 0.70±0.03% and 0.69±0.03%, respectively (p<0.05). 365 
 366 
Figure 5: Bioaccessibility, stability and effective bioavailability of vitamin E loaded Pickering emulsions 367 
with different particle’s sizes (NET-low= ~7 µm, NET-middle: ~11 µm; NET-high: ~18 µm) after in vitro 368 
digestion. Different letters in each evaluated parameter represent significant differences between the 369 
tested Pickering emulsions (p<0.05; one-way ANOVA): a-b for bioaccessibility, A-B for stability, and x-y for 370 
effective bioavailability. 371 
 372 
The low observed bioaccessibility for the tested PEs can be attributed to the high amount 373 
of free Ca2+ ions derived from the n-HAp particles disruption in the gastric phase. Ca2+ 374 
ions can form insoluble aggregates with anionic species, such as bile salts and free fatty 375 

































2- species (random calcium phosphates). These aggregates can entrap 377 
the lipidic phase, hindering its digestion and, consequently, the micellar phase formation. 378 
The CLSM images taken after the intestinal phase (Figure 6) support this hypothesis. In 379 
fact, the insoluble aggregates (stained in red) and the lipidic phase (stained in green) are 380 
superimposed, meaning that some lipidic phase remained entrapped inside these 381 
structures. In addition, the insoluble aggregates can also entrap the mixed micelles 382 
containing the vitamin E, fact in accordance with the observed high stability and low 383 
bioaccessibility, as also reported by (Yang et al., 2015) in a work addressing vitamin E. 384 
Zhou et al. (2020), which compared the effect of using PEs produced with nanochitin 385 
particles with emulsions produced with Tween 80 on vitamin D3 bioaccessibility, reported 386 
a lower bioaccessibility for PEs. The authors justified these results by the precipitation of 387 
the mixed micelles in the presence of the nanochitin together with the presence of the 388 
non-digested vitamin D3 lipid phase carrier. Additionally, Tan et al. (2020) examined the 389 
impact of using chitosan on vitamin D3 bioaccessibility with results showing that it 390 
promoted severe droplet flocculation in the small intestine, reducing the amount of free 391 
fatty acids and leading vitamin D3 bioaccessibility decrease. This effect was justified by 392 











Figure 6: CLSM images Pickering emulsions (NET-low, NET-middle and NET-high) after intestinal 396 
phase.  397 
 398 
The NET-high sample presented a slightly, but significantly higher vitamin E 399 
bioaccessibility, comparatively with the other tested emulsions (p<0.05). This can be 400 
associated to the observed droplet size for this emulsion after the gastric phase. Once the 401 
NET-high sample had a higher droplet size, the lipid digestion rate at the intestinal phase 402 
was, probably, slower than the ones of other emulsions, meaning that the formation of the 403 
mixed micelles delayed the Ca2+ ions binding to other ionic species. Therefore, the 404 
presence of Ca2+ ions showed to have a high impact on vitamin E bioaccessibility and 405 
stability. Moreover, the PE produced with the larger particle size (NET-high) lead to 406 
better results in terms of vitamin E bioaccessibility. 407 
3.3 Vitamin E fortified foods 408 
The PE presenting the best vitamin E bioaccessibility after digestion (NET-high) was 409 
incorporated in gelatine and milk to study the effect of the food matrix in this parameter. 410 









carbohydrates. Both foods are widely consumed. Inorganic solid particles are usually 412 
used in the food industry to modify properties such as viscosity, brightness, and whiteness 413 
(Weir, Westerhoff, Fabricius, Hristovski, & von Goetz, 2012; Zhou et al., 2021). In this 414 
work, the n-HAp solid particles were used as stabilizers in PEs for vitamin E carriers, 415 
thus contributing to the organoleptic properties and to add functional properties to foods. 416 
Figure 7 shows the photos of the used food matrices, gelatine (Figure 7-A) and milk 417 
(Figure 7-B) without incorporation (control samples) and after the incorporation of the 418 
vitamin E-loaded PE (fortified foods). In gelatine, the emulsion addition changes the 419 
sample from transparent to white, effect clearly observed. Regarding milk, no significant 420 
macroscopic changes in terms of colour were observed. In Figure 7-A1 and A2, and 421 
Figure 7-B1 and B2 the optical microscopy images of gelatine and milk (control sample 422 
and fortified food, respectively) are shown. It is possible to observe a clean and 423 
homogeneous image for the control food matrices, whereas for the fortified foods the 424 
presence of the PE is noticeable. To note that the Pickering droplets remained with their 425 
typical morphology and size after incorporation. 426 
 427 
Figure 7: Photos of control samples and fortified foods: gelatine (A) and milk (B). Optical microscopy 428 
images for gelatine and milk controls, (A1 and B1, respectively), and fortified gelatine and milk (A2 and 429 









After emulsion incorporation, the fortified foods (fortified milk and fortified gelatine) 431 
were digested to access vitamin E stability and bioaccessibility. To check for any food 432 
matrix or PE materials effects, control samples (foods without incorporation, and foods 433 
added with non-loaded PEs) were also in vitro digested to determine vitamin E presence. 434 
Figure 8 shows the stability, bioaccessibility and bioavailability of the vitamin E after 435 
fortified gelatine and fortified milk digestion, the statistical analysis was done to compare 436 
the fortified foods for each evaluated parameter. In general, the two fortified foods lead 437 
to good vitamin E stability, with fortified gelatine (gelatine_VitE-PE) showing higher and 438 
statistically different vitamin E stability, comparatively with fortified milk (milk_vitE-439 
PE), namely 49.2±2.28% and 38.4±1.10%, respectively (p<0.05). Comparing the two 440 
fortified foods, the milk_vitE-PE sample presented higher and statistically different 441 
bioaccessibility, 18.1±2.90%, in comparison with 10.9±1.04% for gelatine_VitE-PE 442 
(p<0.05). In addition, milk_vitE-PE presented higher and statistically different 443 
bioavailability than gelatine_VitE-PE (6.93±1.09% and 5.33±0.36%, respectively) 444 
(p<0.05). To note that the control samples (foods without incorporation) presented no 445 
vitamin E (data not shown). In the case of foods added with non-loaded PEs, only a very 446 
residual vitamin E content, attributed to the sunflower oil, was detected (data not shown). 447 
Thus, the quantified vitamin E after digestion of the fortified foods was related to the 448 










Figure 8: Bioaccessibility, stability and adequate bioavailability of fortified food with vitamin E loaded 451 
Pickering emulsions (NET-high: ~18 µm) after in vitro digestion. Different letters represent significant 452 
differences between fortified food matrices in each parameter (p<0.05; t-test): a-b for bioaccessibility, A-B 453 
for stability, and x-y for adequate bioavailability. 454 
 455 
One important point to highlight is the fact that fortified foods lead to better vitamin E 456 
bioaccessibility and stability in comparison with the non-incorporated vitamin E-loaded 457 
PEs. Namely, for vitamin E-loaded PEs, the maximum achieved bioaccessibility and 458 
stability values were 3.29±0.57% and 28.9±2.59%, receptively, for the sample NET-high, 459 
which is much lower than the values obtained with fortified milk (18.1±2.90% and 460 
38.4±1.10% for bioaccessibility and stability, receptively) and fortified gelatine 461 
(10.9±1.04% and 49.2±2.28% for bioaccessibility and stability, respectively). The natural 462 
presence of macronutrients in the fortified foods led to a vitamin E bioaccessibility 463 
increase, possibly associated with their ability to displaced some n-HAp particles from 464 
the oil droplet’s surface, facilitating lipid digestion, vitamin E release and solubilisation, 465 
and mixed micelles formation (Zhou et al., 2020). Furthermore, fortified milk presented 466 
a slightly higher bioaccessibility than gelatine, which can be related to fat presence in this 467 
food matrix, which can improve the micellar phase formation. This can be explained 468 

























available for their formation. Therefore, if a higher number of mixed micelles can be 470 
formed, more vitamin E can be incorporated leading to an increased bioaccessibility. 471 
Another fact contributing positively to vitamin E bioaccessibility is the lower amount of 472 
n-HAp particles presented in the fortified food. This leads to the formation of less Ca2+ 473 
species, decreasing aggregates formation. Additionally, the incorporation of vitamin E-474 
loaded PE in gelatine and milk also lead to an increased vitamin E stability, which 475 
indicates lower vitamin E loss during GI digestion. 476 
Although considering different lipophilic vitamins, the results reported in the present 477 
work for bioaccessibility agree with those published by Zhou et al. (2021). The plant-478 
based milk fortified with a vitamin D3-loaded emulsion together with nanocellulose or 479 
titanium dioxide particles showed a vitamin D3 bioaccessibility around 20% (Zhou et al., 480 
2021). 481 
4 Conclusion 482 
The interest in using PEs as carriers of lipophilic vitamins, foreseeing their use in fortified 483 
foods, is a topic gathering interest within the scientific community. This implies the 484 
digestion study of both PEs and fortified foods to have a more complete image of the 485 
parameters impacting vitamin bioaccessibility. In this study, n-HAp Pickering emulsions 486 
are proposed as vitamin E carriers, and the impact of droplet size (7.53, 11.56 and 487 
17.72 µm) in vitamin E stability, bioaccessibility and bioavailability was studied. For 488 
that, emulsions with tailored droplet size were produced by NETmix, a static mixer 489 
enabling continuous production at controlled emulsifying conditions. 490 
In terms of digestion, the tested vitamin E-loaded PEs presented similar behaviour along 491 
the GIT, with n-HAp particles being disrupted in gastric conditions with subsequent 492 
formation of aggregates under intestinal environment. The droplet average size impacted 493 









droplet size (17.72 µm), leading to the higher vitamin E bioaccessibility results 495 
(3.29±0.57%). The achieved low values were associated with the entrapment of the oil 496 
phase containing vitamin E within the formed random calcium aggregates (intestinal 497 
phase). When the vitamin E-loaded PE NET-high was incorporated in food matrices 498 
(gelatine and milk), vitamin E bioaccessibility increased significantly (10.87±1.04% for 499 
gelatine and 18.07±2.90% for milk), putting in evidence the positive effect of the food 500 
matrix in the bioaccessibility. 501 
Overall, n-HAp Pickering emulsions offer advantages for vitamin E encapsulation 502 
directed to fortified foods development, a process able to be extended to other lipophilic 503 
vitamins, and to other Pickering stabilizers. The obtained results also pointed out the 504 
interest proceed with further studies, namely to understand the effect of the food matrix 505 
composition in the achieved bioaccessibility. Moreover, it also highlights the importance 506 
of combining the study of PEs with their final applications to evaluate more accurately 507 
the real potential of these innovative solutions. 508 
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NETmix was successfully used to produce vitamin E-loaded Pickering emulsions. 
Hydroxyapatite disrupts in the stomach solubilizing in the aqueous medium. 
The formation of calcium aggregates in the intestine hinder vitamin E bioaccessibility. 
Higher droplet size Pickering emulsions enhanced vitamin E bioaccessibility. 
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